Target intelligence / Profile preview

Tubulin alpha pseudogene 9 (TUBAP9)

Target
TUBAP9
Molecular classification
Other (pseudogene)
01

Overview

Tubulin alpha pseudogene 9 (TUBAP9) is annotated in genome databases as a pseudogene of the alpha-tubulin gene family, often listed as tubulin alpha 1c pseudogene (TUBAP9). Pseudogenes are DNA sequences closely related to functional genes but are generally non-coding and considered non-functional remnants of gene duplication events or retrotransposition. They do not encode active protein products and are not recognized as biologically relevant drug targets, biomarkers, or receptors. The alpha-tubulin family, which includes functional genes like TUBA1A and TUBA4A, is essential for cytoskeletal structure and neurodevelopment, but TUBAP9 itself is not known to have any biological function or disease involvement. As such, it is not considered a therapeutic target. TUBAP9 is a pseudogene and does not produce a functional protein. It is not categorized as a receptor, enzyme, transporter, or therapeutic drug target. Functional alpha-tubulin genes (such as TUBA1A, TUBA1B, TUBA1C) are critical for microtubule formation and neurological development, but pseudogenes like TUBAP9 do not participate in these processes. Referencing it as a drug target or receptor is misleading. If treatment, drug development, or biological function is the focus, actual alpha-tubulin genes (e.g., TUBA1A, TUBA1B) should be used instead. Since TUBAP9 does not encode a protein or play a biological role, there are no drugs that target it, no disease involvement or biomarker status, and no safety concerns described.

Other names
Tubulin alpha 1c pseudogeneTUBAP9

Beyond the preview

Go deeper on Tubulin alpha pseudogene 9 (TUBAP9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin alpha pseudogene 9 (TUBAP9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call